Tag: evusheld

Hỗn hợp kháng thể đơn dòng tác dụng kéo dài Evusheld giúp ngăn ngừa đáng kể nguy cơ COVID-19 tiến triển nghiêm trọng hoặc gây tử vong trong thử nghiệm TACKLE pha III

admin

Kết quả được công bố trên tạp chí The Lancet Respiratory Medicine, chứng minh lợi ích của bộ đôi kháng thể này trong việc điều trị COVID-19 ngoại trú ở mức độ nhẹ đến trung bình Kết quả chi tiết Read More …

Evusheld significantly prevented COVID-19 disease progression or death in TACKLE Phase III treatment trial

admin

Results published in The Lancet Respiratory Medicine support benefits of Evusheld in the outpatient treatment of mild-to-moderate COVID-19 Detailed results from the TACKLE Phase III outpatient treatment trial showed AstraZeneca’s Evusheld (tixagevimab and cilgavimab, formerly AZD7442) provided clinically and statistically Read More …

AstraZeneca to supply the US government with an additional one million doses of Evusheld long-acting antibody combination for the prevention of COVID-19

admin

Builds on initial US government agreement, now totalling 1.7 million doses  Only antibody therapy authorized in the US for pre-exposure prophylaxis of COVID-19 in people who are immunocompromised AstraZeneca today announced the US Department of Health and Human Services has Read More …